An interventional study of Ridge augmentation using chin bone ring with simultaneous implant placement in Ridge Augmentation, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 20 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-11-17.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
The study aims toward using autogenous bone grafts to solve decreased bone quantity in anterior maxilla while allowing the patient to recieve implants simultaneously (same time of grafting).
Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Untreated periodontitis.
Chin bone ring is harvested using surgical guide to augment 1. anterior maxillary defective recent extraction sockets OR 2. remaining roots that need extraction and are accompanied with labial bone loss Associated with simultaneous implant placement with the aid of surgical guides
Procedure: Ridge augmentation using chin bone ring with simultaneous implant placement
surgical guides are to be used to harvest chin bone ring, the rings are to be used for bone augmentation in extraction sockets (salama and salama classsification type II),simultaneously implant placement.
Bone quantity (crestal bone) height)
Cone beam
Time frame: 3 months after operation day
Bone quality (bone density at the ring alveolus interface)
In Hounsfield units making use of ROI region of intrest tool included in the software
Time frame: 3 months after operation day
Plan to share: No
This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University